Impact of artificial liver plasma perfusion combined with plasma exchange therapy on clinical efficacy and short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure with or without HIV infection
The PP + PE artificial liver treatment model effectively promotes liver function recovery and improves clinical status in HBV-ACLF patients, including those with HIV co-infection. This provides a valuable basis for clinical management of co-infected cases. Multicenter prospective studies are needed to confirm its long-term efficacy.
Authors
- Chen Zhu (ORCID: https://orcid.org/0000-0002-1002-8387)
- Bin Wan (ORCID: https://orcid.org/0000-0001-9077-3354)
- Ming Zhou (ORCID: https://orcid.org/0000-0002-7460-550X)
- Chuangjie Mao (ORCID: https://orcid.org/0000-0003-3170-4361)
- Yan Jin (ORCID: https://orcid.org/0000-0002-6118-2069)
- Yonghua Mou (ORCID: https://orcid.org/0000-0002-2520-8671)
- Bei Wu
Institutions
- Public Health Clinical Center of Chengdu (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1186/s12879-025-11496-z
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Sichuan Province